0105 Immuneering Terns Ikena
BioCentury & Getty Images


Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

Jan 5, 2021 | 12:12 PM GMT

With crossover investors lining up to participate, biotechs Immuneering, Terns and Ikena each raised rounds that could augur upcoming public offerings.

The deals come

Read the full 497 word article

How to gain access

Continue reading with a
two-week free trial.